BMS-986020

N/A

Report date: 2026/03/13 20:02:36
NME

Base Information

Drug NameBMS-986020
Drug Alias NameAM-152BMS-986020BMS-986202
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonists
TargetsLysophosphatidic acid receptor Edg-2
Therapy Area/IndicationsImmune System DiseasesPsoriasisScleroderma, Systemic +[4
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesPoland +[9
CombinationsNo
Global Highest StatusDiscontinued (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesBristol-Myers Squibb Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesPsoriasisScleroderma, Systemic +[4

Other Information

ATC CodeN/A
Related LinksN/A